Corcept Therapeutics (CORT) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $118.96 +0.73%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q2 EPS of $0.25, $0.10 better than the analyst estimate of $0.15. Revenue for the quarter came in at $117.7 million versus the consensus estimate of $109.6 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
- Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
